Skip to main content
News   »   Eir Ventures today announced the completion of an investment in Strike Pharma

Eir Ventures today announced the completion of an investment in Strike Pharma

23 Feb, 2022 | Press Releases

Eir Ventures today announced the completion of an investment in Strike Pharma, a Swedish biotechnology company that is developing personalized precision medicines within the immune-oncology space. The technology offers the potential to not only increase therapeutic efficacy, but also to reduce dosage levels thereby minimizing the risk of side effects.

All news articles